View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
May 13, 2022

Suvoda, N-SIDE partner for integrated clinical trial optimisation

Integrating IRT solution during trial protocol development will offer Suvoda better visibility into supply chain parameters.

Clinical trial technology company Suvoda and deep-tech company N-SIDE have signed a collaboration agreement to offer integrated clinical trial optimisation.

Suvoda and N-SIDE collaborated on over 100 clinical trials so far in therapy development, enabling machine learning based on real-time data and improving efficiency in trial supply. 

The IRT product of Suvoda allows the deployment of streamlined resupply approaches with modified algorithms that integrate with forecasting and mathematical optimisation recommendations of N-SIDE. 

This leads to substantial cost savings by lowering drug wastage and expedited timelines of the clinical trial.

The latest collaboration aids in incorporating an adaptable IRT solution during the trial protocol development, proving Suvoda improved visibility into the supply chain parameters based on the talks and finalisation of the protocol. 

Compared to IRT deployment at the last minute, moving IRT more upstream during the startup process aids in eliminating risks and time restrictions.

Furthermore, clients will gain access to N-SIDE’s real-time monitoring of inventories, recruitments and demands, which are backed by Suvoda’s data. 

Together with N-SIDE’s optimisation, contract research organisations (CROs) and sponsors will have an accelerated IRT contracting, set-up and build process, with improved optimisation once the trial is initiated.

Suvoda Global Partnerships vice-president Anthony Encarnacao said: “N-SIDE has a history of excellence in clinical supply optimisation that is unrivalled in the industry, and Suvoda is known for delivering clinical trial technology solutions that are built to manage change quickly. 

“Our seamless integration and deep expertise will enable study teams to focus on other day-to-day decisions while giving them peace of mind in their drug supply strategy.”

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena